Trial intelligence / Profile preview

Comparison of RAS Blockage vs Sodium Depletion in Resistant Hypertension

NCT00224549Phase 4Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Apr 2005
Primary completion
Aug 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of ramipril, bisoprolol in resistant hypertension (RH), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2005; status: completed.

02

Drugs

ramiprilbisoprolol
03

Conditions

resistant hypertension (RH)

Beyond the preview

Go deeper on NCT00224549.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00224549.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call